Axordia collaborates with Lombard Medical Technologies PLC for the development of treatment of Coronary Artery Disease
Axordia Limited announced that it has signed a letter of intent to enter into a collaboration with Lombard Medical Technologies PLC (LMT) to co-develop a new generation of treatment for coronary artery disease - a regenerative stent. The collaboration between Lombard and Axordia is for a two and a half year project to develop a regenerative stent that encourages rather than restricts local vascular repair. Attaching Axordia's proprietary, stem cell-derived endovascular cells to Lombard Medical's PEP(TM) programmable polymer coating on the stent surface shall allow the human body to promote controlled vascular repair and heal the damaged coronary artery vessel wall.
The stent shall represent a major step forward into a new format for stent technology where early healing (endothelialisation) is promoted rather than using cytotoxic drugs on drug eluting stents (DES) which inhibit growth and can cause late stage thrombotic events. As a result this stent technology could revolutionise the DES market, according to Axordia.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Good bacteria that protects against HIV
Genetically altered trees, plants could help counter global warming - Study evaluates prospects for boosting carbon sequestration from the atmosphere by modifying natural biological processes and deploying novel food and fuel crops

Glow Reveals Dangerous Bacteria - Chemiluminescence probes for the rapid and sensitive detection of salmonella and listeria
Study finds breast and ovarian cancer may have similar origins

Chemists unlock the key to improving biofuel and biomaterial production - Spectroscopy method enables future opportunities for looking at complex biomolecules in different plants
Biocitech life science park welcomes Chem-X-Infinity and Spectralys Innovation - Two new arrivals add to Biocitech's success in attracting cutting-edge companies to the Paris life science park

Mechanism that reduces effect of cocaine on brain discovered
Novel Chemotherapy Agent Bendamustine Significantly More Effective First-Line Therapy Than Chlorambucil in CLL - Blood Marrow Normalised in 31% (Versus 2%) of Patients, With Manageable Side-Effects
Livatag follow up demonstrates significant survival increase in advanced hepatocellular carcinoma patients
